Photobiomodulation Light Source Device for Fibromyalgia Pain Relief

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for fibromyalgia, including medications and alternative therapies, often have limited effectiveness in reducing chronic musculoskeletal pain and associated symptoms, necessitating a non-pharmacological approach for improved symptom management.

Innovation Solution

The use of photobiomodulation therapy (PBMT) systems and methods that apply a combination of light signals with different wavelengths in pulsed, continuous, and super-pulsed modes, along with a permanent magnetic field, to stimulate a phototherapeutic response in tender areas, creating a neural blockade to block nocioreceptive pathways and reduce pain sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If medications and alternative therapies are used to treat fibromyalgia, then some symptom reduction is achieved, but the effectiveness is limited and side effects may occur

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces pharmacological treatments (chemical-based) with a photobiomodulation device that uses light energy and magnetic fields to treat fibromyalgia. The device applies red light (630nm), infrared light (810nm), and a magnetic field (300-500 Gauss) to tender points, substituting medications with a non-pharmacological physical therapy approach that avoids medication side effects while aiming to improve treatment effectiveness through targeted energy delivery to specific acupuncture-like points

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the treatment parameters by using specific wavelengths of light (630nm red light, 810nm infrared) and a specific magnetic field strength (300-500 Gauss) applied in pulsed modes (continuous, pulsed, or super-pulsed). These precise parameter changes optimize the photobiomodulation effect on cellular metabolism and pain gate control mechanisms, providing a tailored treatment that addresses the limitations of generic pharmacological approaches

Inventive Principle:
Principle #35Parameter changes

2Reliability

If a combination of light sources and magnetic field is used in the light source device, then the phototherapeutic effect is enhanced, but the device complexity increases

Engineering Contradiction:
Improvephototherapeutic responseVSAvoiddevice structure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges multiple light sources (red light 630nm, infrared light 810nm) with a magnetic field generator (300-500 Gauss) into a single integrated light source device. This combination allows simultaneous delivery of photobiomodulation and magnetic therapy to tender points, creating a synergistic effect that enhances pain relief and reduces inflammation while treating multiple pathological mechanisms through one device rather than requiring separate treatments

Inventive Principle:
Principle #5Merging (Combining)

3Adaptability or versatility

If multiple operating modes (pulsed, continuous, super-pulsed) are implemented, then the treatment adaptability is improved, but the control system complexity increases

Engineering Contradiction:
Improvetreatment flexibilityVSAvoidcontrol system
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent implements dynamic operating modes that allow the light source device to switch between continuous, pulsed, and super-pulsed delivery modes. This dynamic capability enables adaptation to different treatment protocols and patient needs, allowing the same device to deliver various energy patterns (continuous exposure, intermittent pulsing, or high-power super-pulsing) to optimize therapeutic outcomes for different fibromyalgia presentations without requiring multiple separate devices

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

PBMT effectively reduces pain thresholds and improves quality of life for fibromyalgia patients by enhancing ATP production, increasing blood flow, and modulating gene and protein expression, offering a synergistic effect that complements or can be used alongside traditional treatments.

Implementation Method 1

a first light source configured to generate a first portion of a light signal with a wavelength of 630 nm... a second light source configured to generate a second portion of the light signal with a wavelength of 810 nm... a third light source configured to generate a third portion of the light signal with a wavelength of 905 nm

Methodology Applied
Scientific EffectLight Emitting Diode: Light Emitting Diode

Implementation Method 2

a permanent magnet configured to generate a magnetic field having a strength of 300-500 Gauss

Methodology Applied
Scientific EffectMagnetic Field: Magnetic Field

Implementation Method 3

PBMT effectively reduces pain thresholds and improves quality of life for fibromyalgia patients by enhancing ATP production, increasing blood flow, and modulating gene and protein expression

Methodology Applied
Scientific EffectPhotobiomodulation: Absorption (EM radiation)

Data Source

PatentEP3609575B1Light source device for photobiomodulation therapy to reduce the effects of fibromyalgia
Publication Date: 2024.07.31 MULTI RADIANCE MEDICAL
  • EP3609575B1 patent drawingFigure 1~2
  • EP3609575B1 patent drawingFigure 3
  • EP3609575B1 patent drawingFigure 4

AI summary

Photobiomodulation therapy (PBMT) can be applied to a tender area on a subject's body to treat fibromyalgia. A light source device can be contacted to a subject's skin proximal to a tender area on the subject's body. A light signal (with wavelengths from the red to infrared part of the spectrum) can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the tender area. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the tender area to treat fibromyalgia.